Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nadersson Pharma AB
AB
Active
Org 5593555955
Retail sale of pharmaceutical products
· NACE 4773
Est. 2021
1 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Nadersson Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
789
1 191
917
Staff expenses
−37
−794
−504
EBITDA
661
321
358
Depreciation & amort.
—
—
—
EBIT
661
321
358
Net financials
—
13
32
Profit before tax
496
251
390
Tax
−102
−52
−81
Net profit
393
199
309
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
930
1 350
1 028
Equity
418
617
461
Long-term debt
—
—
—
Short-term debt
346
484
318
Total debt
346
484
318
Financial ratios
5-year trend
EBITDA margin
39.0%
This company
15.8%
Market median
+147% vs market
2022
2024
Equity ratio
44.8%
This company
38.2%
Market median
+17% vs market
2022
2024
Return on equity
66.9%
This company
18.4%
Market median
+264% vs market
2022
2024
Net profit margin
33.6%
This company
8.1%
Market median
+315% vs market
2022
2024
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
2022
2024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-12-20 – 2022-12-31
View
PDF
More on Nadersson Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot